Global pathogen reduction systems market is anticipated to a staggering CAGR of around 20% during 2021-2025

NEXT STORY
Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China
PREV STORY
Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on June 9, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library

author_avatar
NASDAQ Market News

23andMe Reports FY2022 Second Quarter Financial Results

author_avatar
NASDAQ Market News

CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis

author_avatar
NASDAQ Market News